抗发作药物是患有结核性硬化综合体的儿童行为问题的轻微原因因素
H M Hulshof1, J K Heijstek2, W M Otte1
1Department of Pediatric Neurology, UMC Utrecht Brain Center, Utrecht, the Netherlands.
Epilepsy & behavior : E&B
|April 19, 2025
概括
这项研究没有发现任何证据表明,特定的抗发作药物 (ASM) 会使患有结核硬化综合症 (TSC) 和的儿童的行为问题恶化. 在管理TSC症状方面,ASM的好处可能超过潜在的行为风险.
科学领域:
- 神经科学是一个神经科学.
- 儿科 儿科 儿科
- 药理学 药理学是指药理学的学科.
背景情况:
- 行为问题严重加重患有结核性硬化综合体 (TSC) 的患者和护理人员的负担,往往缺乏明确的病因.
- 抗发作药物 (ASM) 常用于TSC,但它们对行为问题的影响需要进一步调查.
研究的目的:
- 研究特定抗发作药物 (ASM) 与被诊断为结核性硬化综合体 (TSC) 和的儿童的行为表现之间的关系.
- 确定某些ASM是否与行为问题的增加或减少有关,包括侵略性,注意力缺陷,饮食和睡眠障碍,以及怒.
主要方法:
- 一项回顾性队列研究包括118名患有TSC和的儿童 (年龄在2-18岁).
- 行为问题被分类,并分析它们与特定ASM与任何其他ASM之间的关联,使用ASM启动后90天内的几率比率.
- 使用多变量多项逻辑线性建模,将行为问题与疾病特征联系起来.
主要成果:
- 66%的患者报告了行为问题,其中气发作是最常见的 (53%).
- 没有显著的证据表明特定的ASM加重了行为问题.
- 智力障碍和自闭症谱系障碍与注意力和睡眠问题有关.
结论:
- 该研究没有发现特定抗发作药物与TSC儿童行为问题的恶化之间存在因果关系.
- 在管理与TSC相关的时,ASM的潜在治疗益处可能会超过观察到的行为问题的风险.
相关概念视频
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
199
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
199
01:08Antiepileptic Drugs: Sodium Channel Blockers
301
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
301
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
293
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
293
01:17Antiepileptic Drugs: Calcium Channel Blockers
266
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
266
01:24Arteries of the Lower Limbs
172
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
172
01:14Antiepileptic Drugs: Glutamate Antagonists
260
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
260